Patents by Inventor Cephalon, Inc.

Cephalon, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modafinil Formulations
    Publication number: 20130156825
    Abstract: The invention provides an oral pharmaceutical composition comprising modafinil particles, wherein at least about 5% of said modafinil particles have a diameter greater than 200 microns.
    Type: Application
    Filed: February 21, 2013
    Publication date: June 20, 2013
    Applicant: CEPHALON, INC.
    Inventor: Cephalon, Inc.
  • Methods for the Sterilization of Bendamustine
    Publication number: 20130144068
    Abstract: The present application is directed to methods of sterilizing bendamustine and its pharmaceutically acceptable salt forms. Preferred sterilization methods include dry heat sterilization, gamma irradiation, and e beam radiation. Sterile pharmaceutical compositions are also described.
    Type: Application
    Filed: January 9, 2013
    Publication date: June 6, 2013
    Applicant: Cephalon, Inc.
    Inventor: Cephalon, Inc..
  • Method for Purifying a Fused Pyrrolocarbazole Derivative
    Publication number: 20130123499
    Abstract: The present invention relates a method for purifying a fused pyrrolocarbazole compound known as 11-isobutyl-2-methyl-8-(2-pyrimidinylamino)-2,5,6,11,12,13-hexahydro-4Hindazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one using an acid complex thereof. The present invention also relates to a crystalline form of the acid complex.
    Type: Application
    Filed: November 16, 2012
    Publication date: May 16, 2013
    Applicants: CEPHALON FRANCE, CEPHALON, INC.
    Inventors: Cephalon, Inc., Cephalon France
  • Modafinil Compositions
    Publication number: 20130096345
    Abstract: Polymorphs and solvates of racemic, enantiomerically pure, and enantiomerically mixed modafinil are formed and discussed. In addition, said forms are described as useful for the treatment of many conditions including, but not limited to, narcolepsy.
    Type: Application
    Filed: December 6, 2012
    Publication date: April 18, 2013
    Applicant: CEPHALON, INC.
    Inventor: CEPHALON, INC.
  • TUMOR NECROSIS FACTOR INHIBITORS
    Publication number: 20130072562
    Abstract: The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-? mediated conditions.
    Type: Application
    Filed: October 18, 2012
    Publication date: March 21, 2013
    Applicants: CEPHALON, INC., THE TRUSTEES OF THE UNIVERSITY OF PENNSYVANIA
    Inventors: The Trustees Of The University Of Pennsyvania, Cephalon, Inc.